FDA OKs New Non-Statin, LDL-C Lowering Treatment
Esperion bempedoic acid (Nexletol) tablet has gained FDA approval for use in lowering low-density lipoprotein cholesterol (LDL-C) in adults with heterozygous familial hypercholesterolemia (HeFH) or…
February 26, 2020
FDA Endorses First Generic Of ProAir HFA
The U.S. Food and Drug Administration (FDA) has accepted the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the therapy or blocking of…